NCT03409276 · Interventional trial
Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults
Overall registry status Completed
Phase 1
Conditions HIV Infections
Delaware Valley sites
- Penn Prevention CRS · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory